Recommendation ID
MTG19/1
Question
NICE considered that further research on the geko device in clinical settings could focus on reducing the current uncertainties about the reduction in relative risk in the defined patient population, and allow investigation into its use in broader patient populations.
Any explanatory notes
(if applicable)
None.

Source guidance details

Comes from guidance
The geko device for reducing the risk of venous thromboembolism
Number
MTG19
Date issued
June 2014

Other details

Is this a recommendation for the use of a technology only in the context of research? No  
Is it a recommendation that suggests collection of data or the establishment of a register?   No  
Last Reviewed 13/10/2014